The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Sourcing · Independent verification · continued

How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ posts 31–60

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

PW
PharmNotes_WhitfieldTL4Pharmacist30 Apr 2025#31

Marking my place. If it changes for me I will come back and say so.

0 likes 15mo
NK
n.kuuselaTL230 Apr 2025#32

Worth separating two things that post #30 runs together.

Two claims get bundled together under Janoshik and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not.

Almost every disagreement in threads like this one dissolves once you say which of the two you are making.

0 likes 15mo
DO
dr_okonkwoTL4 Moderator1 May 2025#33
j.habermann, post #3: Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. Anyone who has looked at this more carefully, please correct the record. Go to post

The most useful thing anyone has posted about Janoshik in this category was a table of what had been measured and by whom. That is what I would want again.

5 likes in reply to #3 15mo
SC
s.cabreraTL21 May 2025#34

Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies reproducibility but uses the same method.

That is a description of practice, not a recommendation of it.

14 likes 15mo
DH
dietitian_hollisTL31 May 2025#35
EH
e.halonenTL21 May 2025#36

Post #34 and I disagree about the size of the effect, not about the direction.

Speaking only to Janoshik as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.

2 likes 15mo
NA
n.abernathyTL3Analytical chemist2 May 2025#37
e.halonen, post #36: Post #34 and I disagree about the size of the effect, not about the direction. Speaking only to Janoshik as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect. Go to post

Narrowing post #36, because the general version has more than one answer.

Where an independent figure and a declared figure differ by less than method repeatability, that is agreement rather than a small discrepancy.

Worth one more sentence than it usually gets.

9 likes in reply to #36 15mo
PM
p.mwangiTL22 May 2025#38
n.serrano, post #8: Taking post #5 at face value and following it one step further. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is usually faster than testing. Go to post

What would change my mind on Janoshik is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

20 likes in reply to #8 15mo
SS
steady_stateTL3Regular2 May 2025#39

Janoshik would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.

21 likes 15mo
TK
t.karlsenTL22 May 2025#40
e.nilsen, post #22: Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. Go to post

A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.

Reading it again, the caveat matters more than the finding.

0 likes in reply to #22 15mo
ER
eire_readerTL2Regional · IE3 May 2025#41

Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time. VendorInvestigate reviews are documentation assessments. We cite all four because they answer different questions.

Stating my assumptions rather than smuggling them in.

24 likes 15mo
FH
f.haddadTL23 May 2025 · edited#42
mi.almeida, post #10: Two questions I would want answered before drawing anything from the Janoshik data above: how were the cases selected, and what happened to the ones that dropped out. Go to post

Picking up post #39: that is the part I would want checked first.

What I would check first on Janoshik is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.

11 likes in reply to #10 15mo
PN
p.novotnyTL2Regular3 May 2025#43

Practical experience of Janoshik, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.

1 like 15mo
MB
m.balogunTL23 May 2025#44

Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.

0 likes 15mo
CP
citation_peakTL3Regular4 May 2025#45
resistance_first, post #25: PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over time rather than at a point in time. Go to post

Helpful, and easy to find again, which is half of what a good reply is.

32 likes in reply to #25 15mo
FY
f.yildizTL24 May 2025#46
n.vukovic, post #15: Nothing to add on the substance. Thank you for taking the question at face value. Go to post

Adding the measurement that post #43 says would settle it.

Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a chromatogram included. Submission is by mail.

16 likes in reply to #15 15mo
W
WendelboeTL2Member4 May 2025#47

Filing a mild objection to the consensus on Janoshik. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.

3 likes 15mo
AV
ai.vukovicTL24 May 2025#48

Janoshik was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.

0 likes 15mo
VS
vial_slopeTL3Regular5 May 2025#49

The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.

12 likes 15mo
NH
n.hartmannTL25 May 2025#50

The claim about Janoshik upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".

4 likes 15mo
LP
l.piresTL25 May 2025#51

Thank you for taking the time. That was more work than a reply usually is.

0 likes 15mo
HM
h.mensahTL25 May 2025#52

I think the Janoshik question is answerable and has not been answered, which is a more optimistic position than most of this thread.

0 likes 15mo
LS
l.solbergTL25 May 2025#53

Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies reproducibility but uses the same method.

7 likes 15mo
EV
e.verhoevenTL26 May 2025#54
d.bramley, post #14: An observation about Janoshik that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private. Go to post

Post #52 put the caveat in the right place and I want to underline it.

Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth more than self-selected ones.

18 likes in reply to #14 15mo
RL
r.laurentTL26 May 2025#55

Janoshik has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.

26 likes 15mo
MP
mira.patelTL4 Admin6 May 2025#56

Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time. VendorInvestigate reviews are documentation assessments. We cite all four because they answer different questions.

One more caveat and then I will stop qualifying: the sample selected itself.

0 likes 15mo
MO
m.onwukaTL26 May 2025#57

Post #54 is the version of this I will quote in future. One addition.

VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing about what is in a container.

4 likes 15mo
OB
owen.bradyTL4 Moderator7 May 2025 · edited#58
aliquot_line, post #21: Worth separating two things that post #18 runs together. A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Go to post

Where I part company with post #56, and it is a narrow parting.

On Janoshik, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.

If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.

12 likes in reply to #21 15mo
SD
s.dialloTL27 May 2025#59

Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is usually faster than testing.

The variance between people here is larger than the effect being discussed.

19 likes 15mo
PP
peak_purityTL3Analytical chemist7 May 2025#60

I read post #56 twice before replying, because I had assumed the opposite.

PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over time rather than at a point in time.

0 likes 15mo